Leading Edge Pharms Inks CBD Product Distribution Deal with MarketHub
Deal provides MarketHub with rights to distribute Leading Edge’s line of CANNAVERA Pain Relief products with major retailers nationwide
Innovative Treatment for Seizures Released by Nature’s Grace and Wellness & JC Pharma Inc
CannatolRx Nasal Rescue Spray is an original forced-air intranasal medication for individuals who suffer from severe seizures
Premier Health signs Partnership Agreement with Navigator Genomics™ to provide Pharmacogenomic Testing & Medical Cannabis Educational Content to Patients
First-of-its kind pharmacogenomic testing examines patient’s genetic metabolism and ability to effectively utilize medical cannabis and 416 of the most popularly prescribed medications
Leading Edge Pharms Establishes LENCURA Direct™ Sales Force to Build Down-Line Sales Channels for Topical CBD Products
Representatives have begun selling Leading Edge’s natural CANNAVERA™ topical product line to individuals and small businesses
Top MMJ Influencers sign Affiliate Education Agreements with Navigator Genomics™ Testing
Navigator’s affiliates receive news articles, cannabis glossaries, videos, webinars, science whitepapers, and medical condition information
Montreal Cannabis Producer Obtains Three Licenses by Health Canada
Great White North Growers, a producer of premium medical and recreational cannabis, announced that it has received three licenses from Health Canada for cultivation, processing and medical sales
Leading Edge Pharms Opens CBD Research and Innovation Center, LENCURA Labs
Leading Edge Pharms announced the opening of the LENCURA Labs Research and Innovation Center in Carlsbad, California
Leading Edge Appoints Dr. Daniel Holsworth as CSO to Head Up Clinical CBD Research
Leading Edge Pharms appoints Dr. Daniel Holsworth, who has 25 years experience in drug discovery and development, its new Chief Science Officer
Study by Tioga Research Supports Efficacy of Liposomal Compound Silvidiol™
Leading Edge Pharma announced results of a study indicating its proprietary CBD-based pain relief and anti-inflammatory agent Silvidiol™ effectively permeates skin to reach somatic and neuropathic sensory receptors
Breaking the Cycle of Opioid Addiction using Cannabis to be Addressed during Upcoming Cannabis Nurses Network Conference
The 2019 Cannabis Nurses Network Conference features three industry heavyweights in a panel titled “Cannabis & Opiate Harm Reduction”